Stocks In News: GETY, SIDU, BIVI
1:10 pm Wednesday, September 07th, 2022
Getty Images (NYSE:GETY) stock is sliding on Wednesday even after renewing a multi-year contract with Amazon (NYSE:AMZN). According to the company, this agreement will continue to have its content appear alongside Alexa products, as well as Fire TV software. Getty Images holds 495 million visual assets that cover sports, news, entertainment, archival, as well as creative images. Peter Orlowsky, senior vice president of Strategic Development at Getty Images, said the following about the deal.
Sidus Space (NASDAQ:SIDU) stock is rising higher on Wednesday after the company announced an agreement with Elon Musk’s SpaceX. That agreement has Sidus Space securing five launch agreements with the rocket company. These will start in early 2023 and will take its LizzieSatTM multi-mission LEO satellites into orbit. Sidus Space already got approval in 2021 to set up a constellation is satellites operating in low earth orbit. The launches will support agreements with NASA and Mission Helios for payload deliveries and space-based data capture.
In a fresh press release from this morning, BioVie (NASDAQ:BIVI) disclosed top-line results from a Phase 2 clinical trial for its Alzheimer’s disease treatment, NE3107. The results were largely positive, and today’s traders are pushing BIVI stock higher as a result. Nevada-based BioVie focuses on developing treatments for chronic, debilitating conditions. Among those treatments is NE3107, which BioVie is testing in patients with mild to moderate Alzheimer’s disease. The company’s target for completion of its Phase 3 trial is mid-2023.
